Study finds strong correlation in sprint times using a motorized resistance device and timing gates, indicating effective performance assessment in elite female athletes.
Wright, WC, Aguiar, EJ, Winchester, LJ, Fedewa, MV, and Esco, MR. Agreement between a motorized resistance device and traditional systems for sprint and change-of-direction testing in female volleyball players. J Strength Cond Res XX(X): 000–000, 2025—The purpose of this study was to determine the agreement between a motorized sprint resistance device (MSRD) and timing gates and an inertial measurement unit (IMU), for assessing time to completion and peak velocity during linear and change-of-direction tasks in elite female volleyball players. Elite volleyball athletes ( n = 16, 19.4 ± 1.5 years, 176.2 ± 10.6 cm, 71.5 ± 11.1 kg) performed the 18.29 m sprint and 5–10–5 drills while being simultaneously assessed using an MSRD, timing gates, and an IMU. Compared with timing gates for measuring sprint (3.09 ± 0.16 seconds) and 5–10–5 (5.08 ± 0.19 seconds) time, the MSRD showed significant ( p < 0.01) mean differences (3.15 ± 0.17 seconds [ p < 0.01, Cohen's d = 0.49, small ]) and 5.16 ± 0.21 seconds [ p < 0.01, Cohen's d = 1.14, moderate ], respectively, but the correlations were very large to nearly perfect ( r = 0.97 and 0.87, respectively). Limits of agreement (LOA) for sprint time were −0.10 ± 0.10 seconds and for 5–10–5 time were 0.23 ± 0.24 seconds. For peak velocity, the mean values from MSRD and IMU for the sprint (4.62 ± 0.34 m·s −1 and 4.72 ± 0.44 m·s −1 , respectively [ p = 0.78]) and 5–10–5 drill (3.91 ± 0.47 m·s −1 and 3.93 ± 0.50 m·s −1 , respectively [ p = 0.98]) were not significantly different. The correlation between the peak velocity values was significant for the sprint ( r = 0.65, p < 0.01), but not for 5–10–5 ( r = 0.25, p = 0.69), with LOA values of 0.03 ± 0.86 m·s −1 and 0.00 ± 0.98 m·s −1 , respectively. The MSRD seems to agree with timing gates for sprint and 5–10–5 time. However, the agreement with IMU for peak velocity is weaker.
No takes yet. Share an insight, caveat, or question.
Wright et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: